| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0663900B1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 09/22/1999 | EP0655063B1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0517836B1 Method and product for promoting hair growth and treating skin conditions |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229408A Dihydroindole derivatives useful as 5-HT-2C receptor antagonists |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229357A Method of inhibiting fibrosis with growth inhibition excitant |
| 09/22/1999 | CN1229086A Method for preparing rare ginsengoside using enzymatic method to modify ginsenoside glycoside |
| 09/22/1999 | CN1229083A Novel phosphononosulfonate compounds and its pharmaceutical compositions |
| 09/22/1999 | CN1228968A Production method for extracting flavonoid compound extract or powder from bamboo leaf |
| 09/22/1999 | CN1045206C Method for preparing cyclic amide derivative |
| 09/22/1999 | CN1045160C Hair growth modification |
| 09/21/1999 | US5955608 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 09/21/1999 | US5955594 Nucleic acids encoding proteins for early liver development |
| 09/21/1999 | US5955593 BH3 interacting domain death agonist |
| 09/21/1999 | US5955589 Gapped 2' modified oligonucleotides |
| 09/21/1999 | US5955585 Catalytic condensation method for the preparation of chlorophyll and bacteriochlorophyll derivatives |
| 09/21/1999 | US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration |
| 09/21/1999 | US5955574 Analogs of parathyroid hormone |
| 09/21/1999 | US5955507 Therapeutic substituted guanidines |
| 09/21/1999 | US5955504 Administering enantiomerically stable antiinflammatory agents/non-steroids/ or a pharmaceutically acceptable salts to treat colon cancer |
| 09/21/1999 | US5955493 Thiamorphinans with neuroprotective activity |
| 09/21/1999 | US5955492 Carboxylic acid indole inhibitors of chemokines |
| 09/21/1999 | US5955491 Method for treating osteoporosis |
| 09/21/1999 | US5955488 Freeze-dried compositions |
| 09/21/1999 | US5955485 2,3-dihydro-imidazo(2,1-b)benzothiazole derivatives |
| 09/21/1999 | US5955482 Use of 1,4-dihydropyridine-3,5-dicarboxylic acid esters as medicaments |
| 09/21/1999 | US5955474 Antiedema agents or diuretic antagonist |
| 09/21/1999 | US5955466 Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
| 09/21/1999 | US5955464 4-anilinoquinazoline derivatives bearing a heteroaryl substituted at the 6-position and possessing anti-cell-proliferation properties |
| 09/21/1999 | US5955453 Membrane-permeant phosphoinositides |
| 09/21/1999 | US5955443 Treatment and diagnosis of diseases or disorders amenable to treatment through modulation of expression of a nucleic acid encoding a platelet endothelial cell adhesion molecule-1 (pecam-1; also known as cd31 antigen or endocam) protein are |
| 09/21/1999 | US5955440 Macrolide LHRH antagonists |
| 09/21/1999 | US5955430 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 09/21/1999 | US5955424 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/21/1999 | US5955365 Introducing polynucleotides into cells |
| 09/21/1999 | US5955309 Polynucleotide encoding G-protein coupled receptor (H7TBA62) |
| 09/21/1999 | US5955304 DivIB |
| 09/21/1999 | US5955303 Human chemokine receptor-like protein |
| 09/21/1999 | US5955291 Antibodies against extrcellular domain; useful as a diagnostic tool of tumor formation; monitoring of wound healing; imaging agents |
| 09/21/1999 | US5955283 Dna probe useful in diagnosis of diseases related to ion transport in the central and or automonic neverous system; alzheimer's/parkindon's/huntington's diseases |
| 09/21/1999 | US5955282 Human galactosyltransferases |
| 09/21/1999 | US5955278 Polynucleotide sequences coding human protein synthesis controller; useful in diagnosis, prevention, and therapy for apoptosis; antiinflammatory agents; anticarcinogenic agents; antiproliferative agents |
| 09/21/1999 | US5955111 Methods and compositions for inducing production of stress proteins |
| 09/21/1999 | US5955110 Multilayered submucosal graft constructs and method for making the same |
| 09/21/1999 | US5955100 Prodrugs their preparation and use as pharmaceuticals |
| 09/21/1999 | US5955083 Use of eriobotrya japonica extract, in particular in cosmetics for stimulating glycosaminoglycan synthesis |
| 09/21/1999 | CA2192975C Benzimidazolone derivatives |
| 09/21/1999 | CA2135751C 4-mercaptoacetylamino-¬2| benzazepinone(3) derivatives, and use as enkephalinase inhibitors |
| 09/21/1999 | CA2086429C Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 09/16/1999 | WO1999046379A2 Human receptor proteins; related reagents and methods |
| 09/16/1999 | WO1999046367A2 Methods of diagnosis and triage using cell activation measures |
| 09/16/1999 | WO1999046366A1 Uses for humane non-autologous mesenchymal stem cells |
| 09/16/1999 | WO1999046316A2 Enzyme inhibitors |
| 09/16/1999 | WO1999046284A2 Molecules that home to various selected organs or tissues |
| 09/16/1999 | WO1999046282A1 Plasminogen-related gene b polypeptides |
| 09/16/1999 | WO1999046281A2 Novel polypeptides and nucleic acids encoding the same |
| 09/16/1999 | WO1999046279A2 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 09/16/1999 | WO1999046275A1 REPLICATIVE HELICASE dnaB OF $i(STAPHYLOCOCCUS AUREUS) |
| 09/16/1999 | WO1999046274A1 Modified factor viii |
| 09/16/1999 | WO1999046272A1 Serine peptidase modulators |
| 09/16/1999 | WO1999046259A1 5-heteroaryl substituted indoles |
| 09/16/1999 | WO1999046258A1 SUBSTITUTED 2-(2,6-DIOXO-3-FLUOROPIPERIDIN-3-YL)-ISOINDOLINES AND THEIR USE TO REDUCE TNFα LEVELS |
| 09/16/1999 | WO1999046254A2 Amino anthracyclinone derivatives and their use in the treatment of amyloidosis |
| 09/16/1999 | WO1999046248A1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 09/16/1999 | WO1999046242A1 Cycloalkene derivatives, process for producing the same, and use |
| 09/16/1999 | WO1999046240A2 Halogenated amidino amino acid derivatives useful as nitric oxide synthase inhibitors |
| 09/16/1999 | WO1999046237A1 Modulators of protein tyrosine phosphatases |
| 09/16/1999 | WO1999045963A1 Analgesic combination comprising nmda receptor antagonists and narcotic analgesics |
| 09/16/1999 | WO1999045960A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 09/16/1999 | WO1999045952A2 Method of preventing the death of retinal neurons and treating ocular diseases |
| 09/16/1999 | WO1999045949A2 Use of follistatin to modulate gdf-8 and bmp-11 |
| 09/16/1999 | WO1999045947A1 In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
| 09/16/1999 | WO1999045945A1 Improved radiation therapy methods |
| 09/16/1999 | WO1999045941A1 Peptide compositions and formulations and use of same |
| 09/16/1999 | WO1999045939A1 Fibrinogen receptor antagonists |
| 09/16/1999 | WO1999045933A1 Novel delivery of hydroxy carboxylic acids |
| 09/16/1999 | WO1999045931A1 Epiallopregnanolone in the treatment of cns disorders |
| 09/16/1999 | WO1999045927A1 Vitronectin receptor antagonists |
| 09/16/1999 | WO1999045925A1 Novel opiate compounds, methods of making and methods of use |
| 09/16/1999 | WO1999045924A1 Composition |
| 09/16/1999 | WO1999045923A1 Methods of inhibiting bone resorption |
| 09/16/1999 | WO1999045922A1 Lipoic acid analogs |
| 09/16/1999 | WO1999045919A1 Phenanthrofuran derivatives |
| 09/16/1999 | WO1999045916A2 Novel methods for treating disorders in which docosahexaenoic acid (dha) levels are affected |
| 09/16/1999 | WO1999045915A1 Use of alpha-rar antagonists for inhibition of mucin secretion |
| 09/16/1999 | WO1999045913A1 Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
| 09/16/1999 | WO1999045910A2 Methods and compositions for treating and preventing mucositis |
| 09/16/1999 | WO1999045909A2 Use of nitrone compounds for the inhibition of angiogenesis |
| 09/16/1999 | WO1999045907A2 Metal chelators for use in the treatment of alzheimer's disease |
| 09/16/1999 | WO1999045788A1 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 09/16/1999 | WO1999045779A1 Novel compositions of eprosartan |
| 09/16/1999 | WO1999045776A1 Treatment of respiratory disease and otitis media |
| 09/16/1999 | WO1999045775A1 Compositions and methods for modulating vascularization |
| 09/16/1999 | WO1999045770A1 Skin equivalent and methods of forming and using same |
| 09/16/1999 | WO1999036091A3 Method for inhibiting cd95-independent apoptosis in aids |
| 09/16/1999 | WO1999035243A3 Extension of cellular lifespan, methods and reagents |
| 09/16/1999 | WO1999034785A3 Treatment of dyskinesias |